Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

AbbVie Inc (NYSE:ABBV)

69.95
Delayed Data
As of Aug 04
 +0.22 / +0.32%
Today’s Change
51.37
Today|||52-Week Range
71.60
+6.89%
Year-to-Date

Today’s Trading

Previous close69.73
Today’s open70.04
Day’s range69.67 - 70.39
Volume5,410,932
Average volume (3 months)9,627,790
Market cap$111.1B
Dividend yield2.92%
Data as of 4:02pm ET, 08/04/2015

Growth & Valuation

Earnings growth (last year)-57.03%
Earnings growth (this year)+28.27%
Earnings growth (next 5 years)+13.75%
Revenue growth (last year)+6.23%
P/E ratio62.0
Price/Sales5.28
Price/Book63.70

Competitors

 Today’s
change
Today’s
% change
BMYBristol-Myers Squibb-0.50-0.77%
GSKGlaxoSmithKline-0.06-0.14%
CELGCelgene-0.39-0.30%
NVONovo Nordisk-0.37-0.61%
Data as of 4:03pm ET, 08/04/2015

Financials

Next reporting dateOctober 23, 2015
EPS forecast (this quarter)$1.07
Annual revenue (last year)$20.0B
Annual profit (last year)$1.8B
Net profit margin8.89%

Profile

Sector
Health Technology
Industry
Pharmaceuticals: Major
Chairman &
Chief Executive Officer
Richard A. Gonzalez
Senior Vice President-
Operations
Azita Saleki-Gerhardt
Corporate headquarters
North Chicago, Illinois

Forecasts